Sign Up to like & get
recommendations!
1
Published in 2018 at "ACS Omega"
DOI: 10.1021/acsomega.8b01214
Abstract: Cytosolic phospholipase A2 (GIVA cPLA2) has attracted great interest as a medicinal target because it initiates the eicosanoid cascade and is involved in a number of inflammatory diseases. As a consequence, the development of potent…
read more here.
Keywords:
highly potent;
oxoester;
cytosolic phospholipase;
giva cpla2 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-07330-5
Abstract: Cytosolic phospholipase A2 (GIVA cPLA2) is the only PLA2 that exhibits a marked preference for hydrolysis of arachidonic acid containing phospholipid substrates releasing free arachidonic acid and lysophospholipids and giving rise to the generation of…
read more here.
Keywords:
giva cpla2;
potent selective;
phospholipase;
novel class ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Biomolecules"
DOI: 10.3390/biom10030491
Abstract: 2-Oxoesters constitute an important class of potent and selective inhibitors of human cytosolic phospholipase A2 (GIVA cPLA2) combining an aromatic scaffold or a long aliphatic chain with a short aliphatic chain containing a free carboxylic…
read more here.
Keywords:
oxoester;
metabolic stability;
phospholipase;
stability ... See more keywords